Annual FCF
-$18.88 M
-$6000.00-0.03%
31 December 2023
Summary:
BioLife Solutions annual free cash flow is currently -$18.88 million, with the most recent change of -$6000.00 (-0.03%) on 31 December 2023. During the last 3 years, it has fallen by -$20.89 million (-1038.32%). BLFS annual FCF is now -1038.32% below its all-time high of $2.01 million, reached on 31 December 2020.BLFS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$3.69 M
-$1.78 M-32.50%
30 September 2024
Summary:
BioLife Solutions quarterly free cash flow is currently $3.69 million, with the most recent change of -$1.78 million (-32.50%) on 30 September 2024. Over the past year, it has increased by +$9.56 million (+162.77%). BLFS quarterly FCF is now -32.50% below its all-time high of $5.46 million, reached on 30 June 2024.BLFS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$5.65 M
+$9.56 M+244.45%
30 September 2024
Summary:
BioLife Solutions TTM free cash flow is currently $5.65 million, with the most recent change of +$9.56 million (+244.45%) on 30 September 2024. Over the past year, it has increased by +$22.45 million (+133.64%). BLFS TTM FCF is now at all-time high.BLFS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLFS Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -0.0% | +162.8% | +133.6% |
3 y3 years | -1038.3% | +1221.0% | +144.7% |
5 y5 years | -1121.6% | +252.2% | +147.4% |
BLFS Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -1038.3% | at low | -32.5% | +130.9% | at high | +123.0% |
5 y | 5 years | -1038.3% | at low | -32.5% | +130.9% | at high | +123.0% |
alltime | all time | -1038.3% | at low | -32.5% | +130.9% | at high | +123.0% |
BioLife Solutions Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $3.69 M(-32.5%) | $5.65 M(-244.5%) |
June 2024 | - | $5.46 M(-213.1%) | -$3.91 M(-77.9%) |
Mar 2024 | - | -$4.83 M(-463.2%) | -$17.70 M(-6.2%) |
Dec 2023 | -$18.88 M(+0.0%) | $1.33 M(-122.6%) | -$18.88 M(+12.4%) |
Sept 2023 | - | -$5.88 M(-29.4%) | -$16.80 M(+41.5%) |
June 2023 | - | -$8.33 M(+38.6%) | -$11.88 M(-23.4%) |
Mar 2023 | - | -$6.01 M(-276.2%) | -$15.50 M(-17.9%) |
Dec 2022 | -$18.87 M(+45.4%) | $3.41 M(-458.8%) | -$18.87 M(-23.3%) |
Sept 2022 | - | -$950.00 K(-92.1%) | -$24.62 M(+2.6%) |
June 2022 | - | -$11.95 M(+27.4%) | -$24.00 M(+10.2%) |
Mar 2022 | - | -$9.38 M(+300.9%) | -$21.79 M(+67.9%) |
Dec 2021 | -$12.98 M(-745.0%) | -$2.34 M(+611.2%) | -$12.98 M(+2.6%) |
Sept 2021 | - | -$329.00 K(-96.6%) | -$12.64 M(-2.3%) |
June 2021 | - | -$9.74 M(+1602.3%) | -$12.94 M(-1538.9%) |
Mar 2021 | - | -$572.00 K(-71.5%) | $899.00 K(-55.3%) |
Dec 2020 | $2.01 M(+274.0%) | -$2.01 M(+223.0%) | $2.01 M(-25.4%) |
Sept 2020 | - | -$621.00 K(-115.2%) | $2.70 M(-38.2%) |
June 2020 | - | $4.10 M(+657.5%) | $4.36 M(-6613.4%) |
Mar 2020 | - | $541.00 K(-140.9%) | -$67.00 K(-112.5%) |
Dec 2019 | $538.00 K(-70.9%) | -$1.32 M(-226.3%) | $538.00 K(-76.4%) |
Sept 2019 | - | $1.05 M(-414.4%) | $2.28 M(+29.1%) |
June 2019 | - | -$333.00 K(-129.1%) | $1.77 M(-33.1%) |
Mar 2019 | - | $1.15 M(+170.3%) | $2.64 M(+43.0%) |
Dec 2018 | $1.85 M(+300.9%) | $424.00 K(-20.3%) | $1.85 M(-15.0%) |
Sept 2018 | - | $532.00 K(-1.7%) | $2.17 M(+27.6%) |
June 2018 | - | $541.00 K(+54.1%) | $1.70 M(+67.3%) |
Mar 2018 | - | $351.00 K(-53.2%) | $1.02 M(+121.0%) |
Dec 2017 | $461.00 K(-108.3%) | $750.30 K(+1128.0%) | $460.90 K(-137.6%) |
Sept 2017 | - | $61.10 K(-142.4%) | -$1.23 M(-48.1%) |
June 2017 | - | -$144.00 K(-30.3%) | -$2.37 M(-34.6%) |
Mar 2017 | - | -$206.50 K(-78.0%) | -$3.62 M(-35.2%) |
Dec 2016 | -$5.58 M(-12.6%) | -$937.80 K(-12.9%) | -$5.58 M(-11.9%) |
Sept 2016 | - | -$1.08 M(-22.9%) | -$6.34 M(-7.6%) |
June 2016 | - | -$1.40 M(-35.7%) | -$6.86 M(-5.0%) |
Mar 2016 | - | -$2.17 M(+28.7%) | -$7.22 M(+12.9%) |
Dec 2015 | -$6.39 M(+70.4%) | -$1.69 M(+5.7%) | -$6.39 M(+11.3%) |
Sept 2015 | - | -$1.60 M(-9.0%) | -$5.74 M(+15.0%) |
June 2015 | - | -$1.76 M(+30.1%) | -$4.99 M(+19.2%) |
Mar 2015 | - | -$1.35 M(+29.8%) | -$4.19 M(+11.6%) |
Dec 2014 | -$3.75 M(+4036.7%) | -$1.04 M(+22.6%) | -$3.75 M(+42.4%) |
Sept 2014 | - | -$847.40 K(-11.0%) | -$2.64 M(+45.6%) |
June 2014 | - | -$952.40 K(+4.3%) | -$1.81 M(+114.7%) |
Mar 2014 | - | -$912.90 K(-1285.6%) | -$843.10 K(+830.6%) |
Dec 2013 | -$90.70 K(-69.4%) | $77.00 K(-451.6%) | -$90.60 K(-525.4%) |
Sept 2013 | - | -$21.90 K(-249.0%) | $21.30 K(-120.2%) |
June 2013 | - | $14.70 K(-109.2%) | -$105.30 K(-68.6%) |
Mar 2013 | - | -$160.40 K(-184.9%) | -$335.20 K(+12.9%) |
Dec 2012 | -$296.80 K(-72.6%) | $188.90 K(-227.2%) | -$296.80 K(-58.5%) |
Sept 2012 | - | -$148.50 K(-31.0%) | -$714.70 K(-14.3%) |
June 2012 | - | -$215.20 K(+76.4%) | -$833.60 K(-6.1%) |
Mar 2012 | - | -$122.00 K(-46.7%) | -$887.40 K(-18.1%) |
Dec 2011 | -$1.08 M(-15.4%) | -$229.00 K(-14.4%) | -$1.08 M(-5.5%) |
Sept 2011 | - | -$267.40 K(-0.6%) | -$1.15 M(-4.2%) |
June 2011 | - | -$269.00 K(-15.4%) | -$1.20 M(-1.3%) |
Mar 2011 | - | -$318.10 K(+8.9%) | -$1.21 M(-5.4%) |
Dec 2010 | -$1.28 M(-54.0%) | -$292.10 K(-8.0%) | -$1.28 M(+2.6%) |
Sept 2010 | - | -$317.60 K(+11.7%) | -$1.25 M(-19.3%) |
June 2010 | - | -$284.40 K(-26.5%) | -$1.55 M(-26.5%) |
Mar 2010 | - | -$386.90 K(+49.2%) | -$2.10 M(-24.5%) |
Dec 2009 | -$2.79 M(+29.0%) | -$259.30 K(-57.9%) | -$2.79 M(-10.5%) |
Sept 2009 | - | -$615.60 K(-26.9%) | -$3.11 M(+3.8%) |
June 2009 | - | -$841.80 K(-21.4%) | -$3.00 M(+10.8%) |
Mar 2009 | - | -$1.07 M(+82.6%) | -$2.71 M(+25.4%) |
Dec 2008 | -$2.16 M | -$586.30 K(+16.7%) | -$2.16 M(-5.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2008 | - | -$502.60 K(-8.4%) | -$2.27 M(-16.5%) |
June 2008 | - | -$548.50 K(+5.0%) | -$2.72 M(-1.2%) |
Mar 2008 | - | -$522.60 K(-25.3%) | -$2.76 M(-2.0%) |
Dec 2007 | -$2.81 M(+276.4%) | -$699.50 K(-26.6%) | -$2.81 M(+22.7%) |
Sept 2007 | - | -$953.00 K(+63.8%) | -$2.29 M(+54.4%) |
June 2007 | - | -$581.90 K(+0.3%) | -$1.49 M(+25.8%) |
Mar 2007 | - | -$580.10 K(+225.0%) | -$1.18 M(+57.9%) |
Dec 2006 | -$747.80 K(+26.4%) | -$178.50 K(+23.5%) | -$747.80 K(+6.2%) |
Sept 2006 | - | -$144.50 K(-47.9%) | -$704.30 K(+4.5%) |
June 2006 | - | -$277.50 K(+88.4%) | -$673.90 K(+18.6%) |
Mar 2006 | - | -$147.30 K(+9.1%) | -$568.40 K(-3.9%) |
Dec 2005 | -$591.40 K(-231.6%) | -$135.00 K(+18.3%) | -$591.40 K(+19.1%) |
Sept 2005 | - | -$114.10 K(-33.7%) | -$496.50 K(-7.2%) |
June 2005 | - | -$172.00 K(+1.0%) | -$535.00 K(+2.6%) |
Mar 2005 | - | -$170.30 K(+324.7%) | -$521.30 K(-216.0%) |
Dec 2004 | $449.30 K(-151.9%) | -$40.10 K(-73.7%) | $449.30 K(+557.8%) |
Sept 2004 | - | -$152.60 K(-3.6%) | $68.30 K(-67.2%) |
June 2004 | - | -$158.30 K(-119.8%) | $208.40 K(-40.4%) |
Mar 2004 | - | $800.30 K(-290.0%) | $349.60 K(-140.4%) |
Dec 2003 | -$865.40 K(-68.7%) | -$421.10 K(+3268.8%) | -$865.50 K(+10.6%) |
Sept 2003 | - | -$12.50 K(-26.9%) | -$782.20 K(-66.5%) |
June 2003 | - | -$17.10 K(-95.9%) | -$2.33 M(-15.6%) |
Mar 2003 | - | -$414.80 K(+22.8%) | -$2.76 M(0.0%) |
Dec 2002 | -$2.76 M(-5.4%) | -$337.80 K(-78.4%) | -$2.76 M(+5.1%) |
Sept 2002 | - | -$1.56 M(+248.3%) | -$2.63 M(+48.9%) |
June 2002 | - | -$448.90 K(+8.2%) | -$1.77 M(-22.4%) |
Mar 2002 | - | -$414.80 K(+104.4%) | -$2.28 M(-22.1%) |
Dec 2001 | -$2.92 M(-5.3%) | -$202.90 K(-71.0%) | -$2.92 M(-22.6%) |
Sept 2001 | - | -$700.00 K(-27.0%) | -$3.77 M(-5.6%) |
June 2001 | - | -$958.60 K(-9.6%) | -$4.00 M(+8.7%) |
Mar 2001 | - | -$1.06 M(+0.6%) | -$3.68 M(+19.2%) |
Dec 2000 | -$3.08 M(+1058.2%) | -$1.05 M(+14.4%) | -$3.08 M(+52.0%) |
Sept 2000 | - | -$921.90 K(+44.3%) | -$2.03 M(+83.2%) |
June 2000 | - | -$639.00 K(+36.3%) | -$1.11 M(+136.3%) |
Mar 2000 | - | -$468.90 K(-689.8%) | -$468.90 K(+112.7%) |
Dec 1999 | -$266.30 K(+20.8%) | - | - |
Dec 1998 | -$220.50 K(-88.1%) | $79.50 K(-139.8%) | -$220.50 K(-59.9%) |
Sept 1998 | - | -$200.00 K(-150.0%) | -$550.20 K(-42.1%) |
June 1998 | - | $400.00 K(-180.0%) | -$950.20 K(-53.7%) |
Mar 1998 | - | -$500.00 K(+99.8%) | -$2.05 M(+10.8%) |
Dec 1997 | -$1.85 M(+30.8%) | -$250.20 K(-58.3%) | -$1.85 M(+15.6%) |
Sept 1997 | - | -$600.00 K(-14.3%) | -$1.60 M(-5.9%) |
June 1997 | - | -$700.00 K(+133.3%) | -$1.70 M(+37.8%) |
Mar 1997 | - | -$300.00 K(-57.1%) | -$1.23 M(-53.2%) |
Dec 1996 | -$1.41 M(-33.7%) | - | - |
Sept 1996 | - | -$700.00 K(+199.8%) | -$2.63 M(+23.4%) |
June 1996 | - | -$233.50 K(-84.4%) | -$2.13 M(+12.3%) |
June 1996 | -$2.13 M(+14.7%) | - | - |
Mar 1996 | - | -$1.50 M(+650.0%) | -$1.90 M(+375.0%) |
Dec 1995 | - | -$200.00 K(0.0%) | -$400.00 K(+100.0%) |
Sept 1995 | - | -$200.00 K(-60.0%) | -$200.00 K(-92.9%) |
June 1995 | -$1.86 M(-33.6%) | - | - |
Sept 1994 | - | -$500.00 K(-16.7%) | -$2.80 M(0.0%) |
June 1994 | -$2.80 M(-69.9%) | -$600.00 K(-14.3%) | -$2.80 M(-41.7%) |
Mar 1994 | - | -$700.00 K(-30.0%) | -$4.80 M(-18.6%) |
Dec 1993 | - | -$1.00 M(+100.0%) | -$5.90 M(-23.4%) |
Sept 1993 | - | -$500.00 K(-80.8%) | -$7.70 M(-17.2%) |
June 1993 | -$9.30 M(+97.9%) | -$2.60 M(+44.4%) | -$9.30 M(+38.8%) |
Mar 1993 | - | -$1.80 M(-35.7%) | -$6.70 M(+36.7%) |
Dec 1992 | - | -$2.80 M(+33.3%) | -$4.90 M(+133.3%) |
Sept 1992 | - | -$2.10 M(+200.0%) | -$2.10 M(+200.0%) |
June 1992 | -$4.70 M(+80.8%) | - | - |
June 1991 | -$2.60 M(+100.0%) | - | - |
Sept 1990 | - | -$700.00 K | -$700.00 K |
June 1990 | -$1.30 M | - | - |
FAQ
- What is BioLife Solutions annual free cash flow?
- What is the all time high annual FCF for BioLife Solutions?
- What is BioLife Solutions annual FCF year-on-year change?
- What is BioLife Solutions quarterly free cash flow?
- What is the all time high quarterly FCF for BioLife Solutions?
- What is BioLife Solutions quarterly FCF year-on-year change?
- What is BioLife Solutions TTM free cash flow?
- What is the all time high TTM FCF for BioLife Solutions?
- What is BioLife Solutions TTM FCF year-on-year change?
What is BioLife Solutions annual free cash flow?
The current annual FCF of BLFS is -$18.88 M
What is the all time high annual FCF for BioLife Solutions?
BioLife Solutions all-time high annual free cash flow is $2.01 M
What is BioLife Solutions annual FCF year-on-year change?
Over the past year, BLFS annual free cash flow has changed by -$6000.00 (-0.03%)
What is BioLife Solutions quarterly free cash flow?
The current quarterly FCF of BLFS is $3.69 M
What is the all time high quarterly FCF for BioLife Solutions?
BioLife Solutions all-time high quarterly free cash flow is $5.46 M
What is BioLife Solutions quarterly FCF year-on-year change?
Over the past year, BLFS quarterly free cash flow has changed by +$9.56 M (+162.77%)
What is BioLife Solutions TTM free cash flow?
The current TTM FCF of BLFS is $5.65 M
What is the all time high TTM FCF for BioLife Solutions?
BioLife Solutions all-time high TTM free cash flow is $5.65 M
What is BioLife Solutions TTM FCF year-on-year change?
Over the past year, BLFS TTM free cash flow has changed by +$22.45 M (+133.64%)